Myocardial dysfunction during H1N1 influenza infection

Journal of Critical Care

Volumn 28, Issue 4, 2013, Pages 321-327

  Fagnoul, David ^a   Pasquier, Pierre ^a   Bodson, Laurent ^a   Ortiz, Julian Arias ^a   Vincent, Jean Louis ^a   De Backer, Daniel ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

ARDS; Cardiac function; Cardiac output; Echocardiography; Myocardial depression; Oxygen delivery

Indexed keywords

DOBUTAMINE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; LEVOSIMENDAN; NITRIC OXIDE; BIOLOGICAL MARKER;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BODY POSTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EXTRACORPOREAL OXYGENATION; FEMALE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE FUNCTION; HUMAN; INCIDENCE; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INTENSIVE CARE UNIT; MALE; MYOCARDIAL DISEASE; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ADULT RESPIRATORY DISTRESS SYNDROME; BELGIUM; BLOOD; CHI SQUARE DISTRIBUTION; CRITICAL ILLNESS; ECHOGRAPHY; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HEMODYNAMICS; INFLUENZA; MIDDLE AGED; MYOCARDIAL DEPRESSION; NONPARAMETRIC TEST; OXYGEN DELIVERY; VIROLOGY;

ARDS; CARDIAC FUNCTION; CARDIAC OUTPUT; ECHOCARDIOGRAPHY; MYOCARDIAL DEPRESSION; OXYGEN DELIVERY;

BELGIUM; BIOLOGICAL MARKERS; CARDIAC OUTPUT; CHI-SQUARE DISTRIBUTION; CRITICAL ILLNESS; ECHOCARDIOGRAPHY; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEMODYNAMICS; HUMANS; INCIDENCE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84886649345     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2013.01.010     Document Type: Article

References (32)

1. Dawood F.S., Jain S., Finelli L., et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009, 360:2605-2615.
2. Perez-Padilla R., de lR Z., LS Ponce de, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009, 361:680-689.
3. Dominguez-Cherit G., Lapinsky S.E., Macias A.E., et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009, 302:1880-1887.
4. Jain S., Kamimoto L., Bramley A.M., et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009, 361:1935-1944.
5. Kumar A., Zarychanski R., Pinto R., et al. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 2009, 302:1872-1879.
6. Miller R.R., Markewitz B.A., Rolfs R.T., et al. Clinical findings and demographic factors associated with ICU admission in Utah due to novel 2009 influenza A(H1N1) infection. Chest 2010, 137:752-758.
7. Louie J.K., Acosta M., Winter K., et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA 2009, 302:1896-1902.
8. de Jong M.D., Simmons C.P., Thanh T.T., et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006, 12:1203-1207.
9. Wong S.S., Yuen K.Y. Avian influenza virus infections in humans. Chest 2006, 129:156-168.
10. Salgado D.R., Ortiz J.A., Favory R., et al. Microcirculatory abnormalities in patients with severe influenza A (H1N1) infection. Can J Anaesth 2010, 57:940-946.
11. Karjalainen J., Nieminen M.S., Heikkila J. Influenza A1 myocarditis in conscripts. Acta Med Scand 1980, 207:27-30.
12. Engblom E., Ekfors T.O., Meurman O.H., et al. Fatal influenza A myocarditis with isolation of virus from the myocardium. Acta Med Scand 1983, 213:75-78.
13. Puzelli S., Buonaguro F.M., Facchini M., et al. Cardiac tamponade and heart failure due to myopericarditis as a presentation of infection with the pandemic H1N1 2009 influenza A virus. J Clin Microbiol 2010, 48:2298-2300.
14. Cunha B.A., Syed U., Mickail N. Fulminant fatal swine influenza (H1N1): myocarditis, myocardial infarction, or severe influenza pneumonia?. Heart Lung 2010, 39:453-458.
15. Kumar K., Guirgis M., Zieroth S., et al. Influenza myocarditis and myositis: case presentation and review of the literature. Can J Cardiol 2011, 27:514-522.
16. Cain B.S., Meldrum D.R., Dinarello C.A., et al. Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. Crit Care Med 1999, 27:1309-1318.
17. Schmitt J.M., Vieillard-Baron A., Augarde R., et al. Positive end-expiratory pressure titration in acute respiratory distress syndrome patients: impact on right ventricular outflow impedance evaluated by pulmonary artery Doppler flow velocity measurements. Crit Care Med 2001, 29:1154-1158.
18. World Health Organization Interim WHO guidance for the surveillance of human infection with swine influenza A(H1N1) virus Available at:, Accessed Oct 2012. http://www.who.int/csr/disease/swineflu/WHO_case_definitions.pdf.
19. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
20. Jardin F., Dubourg O., Bourdarias J.P. Echocardiographic pattern of acute cor pulmonale. Chest 1997, 111:209-217.
21. Feissel M., Michard F., Faller J.P., et al. The respiratory variation in inferior vena cava diameter as a guide to fluid therapy. Intensive Care Med 2004, 30:1834-1837.
22. Vieillard-Baron A., Chergui K., Rabiller A., et al. Superior vena caval collapsibility as a gauge of volume status in ventilated septic patients. Intensive Care Med 2004, 30:1734-1739.
23. Parrillo J.E., Burch C., Shelhamer J.H., et al. A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 1985, 76:1539-1553.
24. Parker M.M., Shelhamer J.H., Bacharach S.L., et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984, 100:483-490.
25. Hunter J.D., Doddi M. Sepsis and the heart. Br J Anaesth 2010, 104:3-11.
26. Takano T., Tajiri H., Kashiwagi Y., et al. Cytokine and chemokine response in children with the 2009 pandemic influenza A (H1N1) virus infection. Eur J Clin Microbiol Infect Dis 2011, 30:117-120.
27. Bermejo-Martin J.F., Ortiz de L.R., Pumarola T., et al. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care 2009, 13:R201.
28. Erden I., Erden E.C., Ozhan H., et al. Echocardiographic manifestations of pandemic 2009 (H1N1) influenza a virus infection. J Infect 2010, 61:60-65.
29. Brown S.M., Pittman J., Miller Iii R.R., et al. Right and left heart failure in severe H1N1 influenza A infection. Eur Respir J 2011, 37:112-118.
30. Vieillard-Baron A., Schmitt J.M., Augarde R., et al. Acute cor pulmonale in acute respiratory distress syndrome submitted to protective ventilation: incidence, clinical implications, and prognosis. Crit Care Med 2001, 29:1551-1555.
31. Jardin F., Fourme T., Page B., et al. Persistent preload defect in severe sepsis despite fluid loading: a longitudinal echocardiographic study in patients with septic shock. Chest 1999, 116:1354-1359.
32. Natanson C., Danner R.J., Elin R.J., et al. Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J Clin Invest 1989, 83:243-251.